IJR News — today's news from every sideDerek Foss Ford likely picked the cheaper option, but we can't afford to ignore how this weakens U.S. control over critical auto systems. Jared Kim Authorities should check if older vessels like this one need better tracking equipment. 
United Therapeutics and Denali Outline Pipeline Shifts at Morgan Stanley Conference — 5dBiotech firms Crescent Biopharma, Denali Therapeutics, Kyverna Therapeutics, and United Therapeutics outlined forthcoming data, new indications, and expansive commercial strategies at the Morgan Stanley Global Healthcare Conference, signaling a push into pulmonary fibrosis, CNS, and other large patient populations. Denali highlighted its Avlayah Transport Vehicle platform and CNS programs, while United Therapeutics outlined a four‑product strategy for IPF/PPF and planned NDA activities, underscoring continued innovation and manufacturing expansion across the sector.
Nicole Hardy Shifting focus to larger populations like pulmonary fibrosis makes sense for growth but competition will be fierce.
Elena Vasquez Valuing tunnel work at 23 billion still looks inflated until they deliver more than a handful of miles in Vegas. 
